Interactive Computer-adaptive Chronic Kidney Disease Education Program
ICCKD
A Pilot to Develop and Test an Interactive Computer-adaptive Chronic Kidney Disease Education Program for Hospitalized African American Patients (I-C-CKD)
2 other identifiers
interventional
120
1 country
1
Brief Summary
The goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney disease (CKD). The main question it aims to answer are: does computerized adaptive education (CAE) increase patients' knowledge about CKD self-care and renal replacement therapy (RRT) options compared to usual care (UC) and will CAE will be increase patients' intent to participate in CKD self-care and RRT preparation compared to UC
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2023
CompletedStudy Start
First participant enrolled
May 31, 2023
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedJanuary 8, 2025
August 1, 2024
2 years
May 18, 2023
January 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in CKD Knowledge baseline to post patient education intervention
The Kidney Disease Knowledge Questionnaire (KIKS) is a validated instrument that assesses CKD knowledge. Scores range from 0 (no knowledge)-28 (full knowledge). Change =Post intervention-Baseline scores
Baseline and 1 day post-intervention
Change in Knowledge about end stage kidney disease (ESKD) treatments from baseline to 1 day post patient education intervention
The Kidney Failure Treatment Knowledge is an investigator developed tool that assesses knowledge of 6 ESKD treatment options using a Likert scale (0=no knowledge and 4=a great deal of knowledge). Possible scores range from 0-24
Baseline and 1 day post-intervention
Change in ESKD Treatment Preferences from baseline to 1 day post-intervention
The Kidney Failure Treatment Preferences Survey is an investigator developed tool that assess change in certainty of preference for each of six ESKD treatments. Scores range -12 to 12 with each question scored as -2 extremely unlikely to choose a modality to +2 extremely likely to choose a modality with a change from 0 (in any direction) as an increase in certainty.
Baseline and 1 day post-intervention
Secondary Outcomes (3)
Change in Patient Activation Measure from Baseline to 30 days Post-intervention
Baseline, 1 day post-intervention, and 30 day follow-up
Increase in Health Intent baseline to post intervention (at 1 day and 30 day follow-up)
Baseline, 1 day post-intervention and 30 day follow-up
CKD Self-Management from baseline to 30 day post-intervention
Baseline and 30 day follow-up
Study Arms (2)
Usual Care
ACTIVE COMPARATORThe research assistant (RA) will use tablet to give participants baseline General Health Knowledge and Intent survey and leave printed patient education materials about general health maintenance. In the initial consent, pre-intervention survey and education materials, investigators will not provide CKD specific knowledge or inform participants about their CKD.
Computerized Patient Education
EXPERIMENTALThe RA will assist participants in starting the computer program and encourage review of the advanced CKD education module. The computer-adaptive education module will alter the content of education topics based on some preliminary participant information.
Interventions
The intervention is a culturally tailored computer-based adaptive program (developed during this intervention) to educate patients about kidney disease and renal replacement therapy options.
Computer based patient education materials about general healthy lifestyle that will include information about the importance of a healthy diet, physical activity and medical adherence
Eligibility Criteria
You may qualify if:
- African-American inpatients
- Ages 18-70
- estimated glomerular filtration rate (eGFR)\<45
- Enrolled in the Hospitalist Project
You may not qualify if:
- Does not self-identify as African American
- Not able to consent
- Unable to speak English
- eGFR \<45 due to acute kidney injury
- In Intensive Care Unit
- has had a transplant
- currently on dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Related Publications (1)
King A, Omoniyi T, Zasadzinski L, Gaspard C, Gorman D, Saunders M. Interactive Computer-Adaptive Chronic Kidney Disease (I-C-CKD) Education for Hospitalized African American Patients: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 17;14:e66846. doi: 10.2196/66846.
PMID: 40245387DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milda Saunders, MD
Associate Professor of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2023
First Posted
April 15, 2024
Study Start
May 31, 2023
Primary Completion
June 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
January 8, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available 12 months after study completion and will remain available for 24 months
- Access Criteria
- Require researcher data plan and institutional review board (IRB) approval
Can share individual participant data (IPD) based on researcher data plan and IRB approval